EichorEICHOR
Condition: Solid Pseudopapillary Neoplasm Of The Pancreas Synced from ClinicalTrials.gov · August 06, 2026

Recruiting studies: Solid Pseudopapillary Neoplasm Of The Pancreas

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Phase 1/Phase 2 · 21 location(s) · Children's Oncology Group · NCT04851119Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas
Phase 2 · 1 location(s) · Fudan University · NCT06914674Multicentric Database for Solid Pseudopapillary Neoplasm of the Pancreas
Phase N/A · 1 location(s) · Fudan University · NCT07183280
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.